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What you need to know
• Random, untimed cortisol levels are of limited clinical value
• Cortisol measured at around 8-9 am (when the level is expected to be
highest) is the preferred initial screening test for cortisol deficiency
• If high clinical suspicion for hypercortisolaemia, patients should be
referred to specialist care for testing and interpretation of results
• Dynamic testing is often required to confirm cortisol deficiency or excess
given the pulsatile nature of cortisol secretion and the influence of diurnal
variation, feedback control and stress.
• Salivary cortisol has better specificity for diagnosis of Cushing’s
syndrome than urinary cortisol and is easier to collect; if this test is
available, it is increasingly preferred to urinary free cortisol
A 67 year old woman with no significant medical history
required urgent orthopaedic surgery after a fall. In
preparation, her bloods were collected and a random cortisol
was requested, which came back at 763 nmol/L. She did not
have diabetes or hypertension. The anaesthetist reviewed
and commented: “High cortisol, not safe for surgery until
further evaluation.”
A 24 year old man with previously well controlled type 1
diabetes presented with repeated hypoglycaemic episodes.
Serum cortisol in clinic at 9 am came back as 143 nmol/L.
Cortisol, secreted by the adrenal cortex, regulates blood pressure,
glucose metabolism, and physiological responses to stress. Both
cortisol over-secretion (hypercortisolism, Cushing’s syndrome)
and under-secretion (hypocortisolism such as in Addison’s
disease) are uncommon: the prevalence of Addison’s disease is
6-9 per 100 000,1 while that of Cushing’s syndrome is 4/100
000.2 However, given the potential for life threatening
consequences (such as in acute adrenal crisis) and the range of
associated non-specific symptoms, it is critical for clinicians to
understand how to interpret and manage cortisol status. Cortisol
excess could be due to an adrenal cortisol-secreting tumour or
to a functional pituitary tumour (Cushing’s disease), or, less
commonly, malignant tumours can secrete adrenocorticotrophic
hormone (ACTH) ectopically. Cortisol deficiency could be due
to primary adrenal malfunction (such as autoimmune-mediated
atrophy “Addison’s disease,” malignant infiltration, or
haemorrhage) or secondary to either pituitary or hypothalamic
disease resulting in reduced secretion of ACTH.
Interpreting cortisol results can be confusing because cortisol
secretion is pulsatile, shows diurnal variation, is regulated via
a feedback system, and is influenced by a range of stressors.
Furthermore, the tests involve measuring cortisol on its own
(static testing) or as part of a stimulation or suppression test
(dynamic function testing), and in a range of sample types (such
as from serum, saliva, or urine).
This article is aimed at non-specialist doctors who may need to
order or interpret cortisol blood tests. Grounded in cortisol
physiology, it describes how you might investigate suspected
cortisol deficiency and excess, the practicalities of sample
choice, and correct timing to obtain meaningful results.
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Sources and selection criteria
This article is based on targeted search of online publication databases (https:
//www.nlm.nih.gov/) examining the topic areas listed in the article, including:
• Cortisol physiology, including factors affecting cortisol production
• Cortisol measurement
• Biochemical identification of cortisol excess and deficiency
• Clinical presentation of cortisol excess and deficiency.
Secondary references were identified originating for those identified above,
in addition to those identified through personal and professional networks
(including grey literature, such as professional guidelines), and throughout
the review process.
Factors affecting cortisol production and
measurement
Cortisol is secreted from the adrenal cortex and is influenced
by (fig 1):
Circadian rhythm—Cortisol is secreted in response to pulses
of corticotrophin releasing hormone (CRH) and ACTH.3
These pulses contribute to a circadian rhythm with peak
cortisol levels just before waking and the nadir around
bedtime. Hence, if cortisol deficiency is suspected, cortisol
should be measured at around 8-9 am (when it is expected
to be highest). If this is low, it would suggest deficiency. If
excess cortisol is suspected, cortisol levels should be checked
when they are expected to be lowest (around midnight). A
random, untimed cortisol measurement is of minimal clinical
value and should be avoided in assessing cortisol status.
Feedback control—Exploiting the physiologic feedback
mechanisms is the underlying principle behind dynamic
function tests (both stimulation and suppression tests).4 5
CRH produced in the hypothalamus stimulates the pituitary
to produce ACTH, which stimulates the adrenal gland to
produce and release cortisol.3 6 Rising cortisol levels suppress
further CRH and ACTH production, thereby creating a
negative feedback loop. In cases of cortisol insufficiency
due to adrenal causes, CRH and ACTH levels are expected
to be high. However, in cases of cortisol insufficiency due
to a hypothalamic or pituitary cause (such as a tumour), the
ACTH level would be low. The same principles apply to
cortisol excess.
Stress—Cortisol is often referred to as the stress hormone.
Its secretion is promptly induced in response to a range of
stressors including severe trauma, sepsis, pain, anxiety,
exercise, and hypoglycaemia. The extent of impact on
cortisol levels will depend on the severity of the stress. If
there is suspicion of cortisol deficiency (for example,
unexplained hyponatraemia, hypoglycaemia, or hypotension
in a severely septic patient), interpretation of cortisol levels
should take into account the underlying stress.7
Cortisol binding globulin—Cortisol is bound strongly to
cortisol binding globulin (CBG) in serum. Serum cortisol
measurement reflects the total rather than free concentration.
Factors affecting CBG, such as acute illness or medicines
such as hormonal contraception, could alter reported serum
cortisol without having a bearing on free cortisol
concentrations. In contrast, saliva and urine samples reflect
the free component of cortisol and may thus be clinically
more useful. For example, in a recent study, women taking
the contraceptive pill were found to have total plasma cortisol
and CBG levels 2.9 and 2.6 times higher, respectively, when
compared with controls, whereas 24 hour urinary free cortisol
and plasma free cortisol were not significantly different.8
Given the wide availability of total serum cortisol assays
(which includes the CBG-bound component), the effect of
CBG may need to be taken into consideration.
Exogenous glucocorticoids used for the treatment of other
diseases may also suppress the hypothalamo-pituitary-adrenal
axis. This includes the use of inhaled, nasal, transdermal,
and intra-articular preparations.
When to consider measuring cortisol in
routine clinical practice?
Given the multi-organ impact of cortisol, its measurement may
be considered in a wide range of clinical scenarios in day-to-day
practice. However, adrenal disorders are uncommon. Cortisol
measurement is not routinely required unless there are specific
features to suspect adrenal disease. For example, rapid onset of
diabetes with weight gain, easy bruising, and muscle weakness
could point to possible Cushing’s syndrome. Paradoxically,
unexplained hypoglycaemia or hypotension developing in a
patient with type 1 diabetes or thyroid disease should raise
suspicion for Addison’s disease. Box 1 lists some of the clinical
features that should prompt a clinician to consider measuring
cortisol.
Box 1: When to consider testing cortisol function
Cortisol deficiency9 10
• Unexplained electrolyte imbalance (hyponatraemia, hyperkalaemia)
• Hypotension (especially if resistant or associated with other factors such
as weight loss, electrolyte imbalance, increased pigmentation)
• Unexplained or accelerated weight loss
• Tiredness (unexplained, overwhelming, or associated with other above
symptoms)
• Unexplained reduced appetite, salt cravings, increased thirst or urination,
nausea and vomiting
• Combinations of autoimmune disease (such as type 1 diabetes,
hypothyroidism or hyperthyroidism, vitiligo, pernicious anaemia, chronic
active hepatitis, alopecia, coeliac disease, rheumatoid arthritis)
• Family history of autoimmune disease (as above)
• Hypothyroidism with expected or confirmed autoimmune disease
• Type 1 diabetes with recurrent unexplained hypoglycaemia
• Cancer with bilateral adrenal lesions
• Use of exogenous corticosteroids
• Pregnancy with unexplained persistent nausea, hypotension, and/or
fatigue11
Cortisol excess11
• Unexplained electrolyte imbalance (hypokalaemia)
• Hypertension (especially in young patients, resistant to treatment, or
associated with diabetes, central obesity, increased bruising)
• Unexplained or accelerated weight gain
• Deteriorating diabetes control
• Unexplained bruising
• Adrenal incidentaloma
Cortisol excess could be due to a cortisol-secreting tumour or
to a functional pituitary tumour (Cushing’s disease) secreting
ACTH that is not responsive to the normal negative feedback
loop. Less often, malignant tumours can secrete ACTH
ectopically. Cortisol deficiency could be due to primary adrenal
malfunction (such as autoimmune-mediated atrophy “Addison’s
disease,” malignant infiltration, or haemorrhage) or secondary
to either pituitary or hypothalamic disease resulting in reduced
secretion of ACTH.
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What tests are available and how to
interpret them
In general, initial testing consists of static tests that are timed
to correspond with physiologic diurnal cortisol variation:
• If cortisol excess is suspected, midnight cortisol should be
measured
• If cortisol deficiency is suspected, cortisol levels should
be checked at 8-9 am.
Cortisol testing modalities for both excess and deficiency (with
their advantages and disadvantages) are summarised in table 1.
If initial static tests are abnormal, dynamic tests are then used
to confirm abnormal results. The approach to testing is depicted
in figure 2.
Investigating suspected cortisol excess
There are three tests that can be considered initial screening
tests when investigating suspected hypercortisolism. These are
midnight serum or salivary cortisol, 24 hour urinary free cortisol,
and the overnight dexamethasone suppression test. Serum testing
was extensively used in the past, but it requires hospitalisation
and venepuncture at midnight, causing stress that could falsify
the results. If available, salivary cortisol is increasingly being
used for outpatient testing instead (mostly by specialists).
Although an overnight dexamethasone suppression test is a
dynamic test, it can be performed as an outpatient, and GPs
could consider this test with select patients, particularly when
clinical suspicion is low and testing can be done quickly to rule
out cortisol excess.
While many of these tests can, in theory, be performed by
general practitioners, if they have a high clinical suspicion of
hypercortisolism, we recommend referral to specialist care for
testing because of the complexity of interpreting the results and
potential confounders. See table 1 for a summary of the
non-dynamic tests that could be used to test for cortisol excess.
Baseline (non-dynamic) tests
Serum cortisol—A random cortisol measurement is of limited
clinical value when testing for cortisol excess.
Urinary cortisol—Urinary cortisol testing relies on urine
collection over 24 hours to measure the cumulative cortisol
produced in that time. Although the diagnostic sensitivity
and specificity vary between studies, an elevated 24 hour
urinary cortisol level has been found to be 84-93% sensitive
and 56-79% specific for diagnosis of Cushing's syndrome.12 13
Salivary cortisol—Salivary cortisol has better specificity
than urinary cortisol and is useful for ruling out cortisol
excess. A value above the reference interval has an average
sensitivity of 95% and specificity of 91.6%, depending on
the assay used and the locally derived cut-off value,14 for the
diagnosis of Cushing’s syndrome. Because it is easier to
collect and has the advantage of measuring free rather than
bound cortisol, salivary cortisol has been advocated as a first
line test.13 However, salivary cortisol assays have limited
availability. On balance, clinicians have to rely on the tests
that are available locally: if urinary cortisol is the only
available test, then it will be the first choice, to be followed
by other investigations or referrals as required.
Dynamic testing: the dexamethasone suppression
test
There are different methods for performing this test.15 The
overnight 1 mg dexamethasone suppression test can be
performed on an outpatient basis and consists of a patient taking
1 mg of dexamethasone orally between 11 and 12 pm and then
a serum cortisol sample being taken at 9 am the following
morning.16 A cortisol level of <50 nmol/L has high sensitivity
(95%) and moderate specificity (80%) for excluding Cushing’s
syndrome. It is important to note that some drugs can interfere
with the test results by accelerating dexamethasone metabolism
(such as antiepileptics and rifampicin) or impairing it (such as
diltiazem and fluoxetine). Other drugs, such as oestrogens and
carbamazepine, increase the concentration of cortisol binding
globulin, resulting in falsely elevated cortisol levels. Other forms
of the dexamethasone suppression test (such as the two day,
low dose test) are available and could be considered by
endocrinologists.
Further testing
Once cortisol excess is confirmed, the source of excess
production along the hypothalamo-pituitary-adrenal axis (or
ectopic ACTH secretion) needs to be identified, typically by an
endocrinologist.
Investigating suspected cortisol deficiency
For initial screening of suspected cortisol deficiency, an 8-9 am
cortisol sample is taken to measure cortisol at its expected peak.
Unless the results are reassuring, further discussion or referral
to endocrinology is required. See figure 2 for details.
Non-dynamic serum cortisol testing
Deficiency is highly unlikely if the 8-9 am cortisol level is above
400-475 nmol/L (the exact cut-off will vary depending on the
assay used in the local laboratory). Recent work proposed that
values between 336 and 506 nmol/L had a 100% specificity of
predicting passing a short synacthen test.17 Cortisol levels <150
nmol/L at 8-9 am warrant immediate discussion with, or referral
to, endocrinology, and hydrocortisone replacement should be
started urgently. Cortisol levels between 150 and 400 nmol/L
(or agreed limit from the local laboratory) require further
evaluation to rule out cortisol deficiency. If the sample was not
collected at 8-9 am, then a repeat cortisol measurement can be
performed. If the sample was collected correctly, patients with
levels below 400-475 nmol/L (depending on the local assay
limit), will need follow-up testing with a specialist.
Neither urinary nor salivary cortisol has a role in the assessment
of cortisol deficiency.18
Dynamic tests: short synacthen test
Synacthen mimics the effect of ACTH in stimulating cortisol
production: administration of synacthen should therefore result
in a predictable rise in serum cortisol.5 The short synacthen test
has equivalent performance to that of the gold standard insulin
stress test.4 19 20 As it can be performed in an outpatient setting,
it has become the most common dynamic test of cortisol
deficiency. The cut-off values for a satisfactory response depend
on the cortisol assay used9: 450 nmol/L is the threshold used in
many centres, though this again will need to align with the local
assay.21
Falsely reassuring test results could be obtained in a case of (a)
early pituitary failure before adrenal atrophy develops or (b)
postoperative testing in patients who had recently undergone
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surgical removal of the pituitary gland for Cushing’s syndrome
(as persistent adrenal hypertrophy may lead to adequate
response).
The role of ACTH measurement
ACTH is almost always measured by specialists to determine
the source of cortisol excess or deficiency along the
hypothalamic-pituitary-adrenal axis. For example, in a case of
cortisol excess, low ACTH levels point to an adrenal source. In
practice, for the assessment of cortisol deficiency, baseline
ACTH is measured only if the short synacthen test result is
abnormal.
Exogenous steroids and impact on cortisol
measurement: a pragmatic approach
Patients taking oral glucocorticoids at a dose higher than the
physiological cortisol level (prednisolone 5 mg or
dexamethasone 1-2 mg daily) will have a suppressed
pituitary-adrenal axis. They may need tapered withdrawal of
their glucocorticoids (box 2), but do not need to have their
cortisol concentrations measured routinely.
Box 2: Tapering exogenous glucocorticoids: impact on cortisol
measurement
• Most steroid courses are short (<3 weeks), and so adrenal atrophy is
unlikely and cortisol measurement is not routinely required
• For longer steroid courses (>3 weeks) at higher than physiological
doses, gradual reduction is necessary; again cortisol testing is not
required. If patients feel unwell during steroid withdrawal, they need to
seek medical advice to consider more gradual withdrawal
• In cases of prolonged steroid courses (such as for polymyalgia
rheumatic, which may require courses of several months), more gradual
withdrawal and careful monitoring of symptoms is warranted and is
sufficient in most cases. Cortisol measurement, if required, should be
part of specialist evaluation
Case resolution
In the first case, given the absence of clinical features of
Cushing’s syndrome in this 67 year old woman with
physiological stress due to injury, an elevated random cortisol
level requires no further action and should not delay orthopaedic
management. However, for further reassurance, we would
recommend that the woman is reassessed when she is well.
In the second case, the 9 am cortisol test result <150 nmol/L
required immediate further investigation to rule out cortisol
insufficiency. A dynamic, confirmatory test was performed
along with ACTH testing. Serum cortisol was low and ACTH
was elevated, confirming the diagnosis of primary adrenal
insufficiency. Starting hydrocortisone resulted in resolution of
the hypoglycaemic episodes.
Education into practice
• How do you ensure accurate timing for collection of a 9 am serum
cortisol sample?
• Audit the cortisol requests made in the past six months in your practice
and review the timings and results in relation to the recommendations
in this article.
• Reflect on the last time you considered an adrenal disorder in your
practice. Would the recommendations in this article alter your
management plan?
How patients were involved in the creation of this article
No patient involvement. The cases provided are fictitious but based on
commonly encountered clinical scenarios.
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Table 1| Advantages and disadvantages of different options for cortisol sampling
DisadvantagesAdvantagesRequirementsProcedure
Serum sample
• Invasive test (venepuncture)–Could lead to stress induced
hypercortisolaemia, especially if sample collected at midnight
• Measures total, not free cortisol, so vulnerable to abnormalities
in cortisol binding globulin (CBG):
- During critical illness, CBG may fall and the consequent low total
cortisol may be mistaken for adrenal insufficiency
- Oral contraceptives (oestrogen component) or pregnancy result
in increased CBG, spuriously raising total cortisol levels (but not
influencing free cortisol)
• Interference from exogenous steroids in some assays
• Interference from cortisol precursors in some assays
• Test widely available
• Well characterised cut-off
concentrations
• Early morning (8-9 am)
sample for assessing cortisol
deficiency
• Late evening (11-12 pm)
sample for assessing cortisol
excess
• Random, untimed
cortisol is of limited
clinical value
Saliva sample
• Patients taking diuretics may find it difficult to collect enough
saliva (dry mouth)
• Food or blood contamination (collect ≥60 min after eating or
cleaning teeth)
• Restricted availability—May need to send samples to specialist
laboratories, with implications for cost and turnaround times
• Only of use in identifying cortisol excess
• Potential for “user error” in self sampling of saliva
• Non-invasive test
• Home collection possible
• Convenient for midnight samples
• Measures free cortisol
• Overcomes stress induced
hypercortisolaemia
• Stability at 4°C for 2 weeks
• Food and blood contamination have
no impact if sampling instructions are
followed
• Use synthetic swab or
passive drool (0.5 mL)
• Better specificity for
diagnosis of Cushing’s
syndrome than urinary
cortisol and easier to
collect
Urine sample
• Samples may not represent a full 24 hour collection
• Metabolites may interfere with some assays
• Only of use in identifying cortisol excess




• Measures free cortisol
• Measurement widely available
• 24 hour collection
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Fig 1 How cortisol testing is affected by its underlying physiology
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Fig 2 Action plan for suspected glucocorticoid dysfunction
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